{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:00:54Z","timestamp":1781074854915,"version":"3.54.1"},"reference-count":23,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Breast cancer is among the most common malignancies worldwide and remains a leading cause of cancer-related mortality in women [...]<\/jats:p>","DOI":"10.3390\/ijms27125238","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:33:44Z","timestamp":1781073224000},"page":"5238","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Special Issue \u201cBreast Cancer: From Pathophysiology to Novel Therapies\u201d"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1602-4560","authenticated-orcid":false,"given":"Jennifer","family":"Sims-Mourtada","sequence":"first","affiliation":[{"name":"Cawley Center for Translational Cancer Research, Helen F Graham Cancer Center and Research Institute, Christiana Care Health Services, Inc., 4701 Ogletown Stanton Rd Suite 4300, Newark, DE 19713, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"ref_1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","first-page":"322","article-title":"The treatment of breast cancer in the era of precision medicine","volume":"22","author":"Bai","year":"2025","journal-title":"Cancer Biol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJMoa2511734","article-title":"Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer","volume":"393","author":"Cortes","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40364-024-00633-6","article-title":"Trop2-targeted therapy in breast cancer","volume":"12","author":"Hu","year":"2024","journal-title":"Biomark. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mayrovitz, H.N. (2022). Subtypes of Breast Cancer. Breast Cancer, Exon Publications.","DOI":"10.36255\/exon-publications-breast-cancer"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kudelova, E., Smolar, M., Holubekova, V., Hornakova, A., Dvorska, D., Lucansky, V., Koklesova, L., Kudela, E., and Kubatka, P. (2022). Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232314937"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1172\/JCI60534","article-title":"Heterogeneity in breast cancer","volume":"121","author":"Polyak","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semcancer.2020.12.004","article-title":"The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: Current findings and future perspectives","volume":"82","author":"Sukocheva","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ghafouri-Fard, S., Khanbabapour Sasi, A., Abak, A., Shoorei, H., Khoshkar, A., and Taheri, M. (2021). Contribution of miRNAs in the Pathogenesis of Breast Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.768949"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/bcr2484","article-title":"MicroRNAs and their target gene networks in breast cancer","volume":"12","author":"Lal","year":"2010","journal-title":"Breast Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ren, Q.X., Zhao, Q., Wu, N., Du, W., Liu, Z., Zhang, W.J., and Ren, A.J. (2025). MicroRNA-221: A Context-Dependent Mediator in Human Diseases-Highlights from Molecular Mechanisms to Clinical Translation. Cells, 14.","DOI":"10.20944\/preprints202510.2464.v1"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","article-title":"Molecular mechanisms of tumor resistance to radiotherapy","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.3390\/curroncol29100540","article-title":"Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer","volume":"29","author":"Poddar","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.7150\/ijbs.92125","article-title":"Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer","volume":"20","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Fukano, M., Park, M., and Deblois, G. (2021). Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression. Cancers, 13.","DOI":"10.3390\/cancers13184699"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Munkacsy, G., Santarpia, L., and Gyorffy, B. (2023). Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24086945"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Akinsipe, T., Mohamedelhassan, R., Akinpelu, A., Pondugula, S.R., Mistriotis, P., Avila, L.A., and Suryawanshi, A. (2024). Cellular interactions in tumor microenvironment during breast cancer progression: New frontiers and implications for novel therapeutics. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1302587"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Moura, T., Laranjeira, P., Caramelo, O., Gil, A.M., and Paiva, A. (2025). Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32030143"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41523-023-00543-0","article-title":"Immune landscape of breast tumors with low and intermediate estrogen receptor expression","volume":"9","author":"Voorwerk","year":"2023","journal-title":"npj Breast Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"976","DOI":"10.17305\/bb.2024.11450","article-title":"Research progress and application status of organoid in breast cancer subtypes","volume":"25","author":"Zhang","year":"2025","journal-title":"Biomol. Biomed."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s41467-020-15283-z","article-title":"Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors","volume":"11","author":"Djomehri","year":"2020","journal-title":"Nat. Commun."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5238\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:40:37Z","timestamp":1781073637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":23,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27125238"],"URL":"https:\/\/doi.org\/10.3390\/ijms27125238","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}